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28Nonsurgical treatment of cystic adventitial disease
of the popliteal artery caused by functional popliteal
artery entrapment syndrome
Joseph C. McGinley, MD, PhD, Casper, Wyo; Stanford, Calif; and Seattle, Wash
Lower extremity claudication in young men can be caused by popliteal artery entrapment and vascular pathology. The
case reported here describes a young male wrestler who presented with unilateral calf pain with activity. Imaging studies
at rest demonstrated cystic adventitial disease of the popliteal artery. Stress imaging showed severe functional popliteal
artery entrapment. This patient was treated with an imaging-guided botulinum toxin injection of the muscles at the site of
arterial compression. The patient was asymptomatic 6 weeks after treatment. Repeat stress imaging demonstrated
complete resolution of the entrapment and nearly complete resolution of the popliteal artery cystic adventitial
disease. (J Vasc Surg Cases 2015;1:28-31.)Cystic adventitial disease (CAD) of the popliteal artery
is a rare cause of lower extremity claudication. CAD was
ﬁrst described in the external iliac artery by Atkins and
Key in 1947.1 The disease is most often unilateral, affecting
the popliteal artery (85%).2 Young men, otherwise healthy,
are most commonly affected and often present with inter-
mittent claudication.3 The prevalence is one of every
1200 cases of calf claudication.3
Several etiologies of CAD have been proposed,
including repeated microtrauma with intramural bleeding,
synovial tracking, and true synovial cysts.3-6 Treatment of
CAD can be challenging. Current treatment methods
include image-guided cyst aspiration, surgical cystectomy,
or resection of the affected segment of blood vessel with
placement of a graft.7,8 There have also been rare cases of
spontaneous cysts regression and treatment with percuta-
neous transluminal angioplasty with limited success.9-13
Written consent was obtained from the patient’s parents
to publish this study.
CASE REPORT
A 17-year-old male, right side-dominant wrestler, presented
with right lower extremity pain exacerbated during wrestling prac-
tices and competitions for the past 7 months. The patient
described severe calf and ankle pain of 10 of 10 along with someCasper Medical Imaging, Casper; Stanford University, Stanford; and
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://dx.doi.org/10.1016/j.jvsc.2015.01.002degree of numbness and tingling in his foot. The patient is other-
wise healthy and is a nonsmoker, with no history of vascular dis-
ease, traumatic injury, or prior surgery. Vital signs were normal,
and the patient’s history was otherwise noncontributory.
On physical examination at rest, the patient’s pulses were sym-
metric in the lower extremity. There were no areas of discoloration
or venous varices. The calf muscles were well developed bilaterally.
The patient had normal strength, range of motion, sensation, and
reﬂexes. Bilateral plantar ﬂexion against resistance at 63.5 kg using
the MVP FLEX (MVP Innovations, Casper, Wyo) resulted in re-
creation of the patient’s symptoms in the right leg. There was
also mild pallor of the distal toes of the right foot. The left foot
was normal in appearance.
Noncontrast magnetic resonance imaging demonstrated
abnormal cystic change in the right popliteal artery (Fig 1). A sub-
sequent computed tomography (CT) angiogram was performed at
rest and with plantar ﬂexion against resistance at 63.5 kg using the
MVP FLEX (Fig 2). The CT scan demonstrated a cyst measuring
10  16  48 mm in the wall of the right popliteal artery. In addi-
tion, with stress maneuvers, the imaging demonstrated severe
bilateral functional popliteal artery entrapment syndrome (fPAES)
due to compression by the gastrocnemius muscle (Fig 1).
A treatment was proposed to the patient using an imaging-
guided botulinum toxin injection of the muscle at the site of
vascular compression. A small area of muscle was targeted in the
bilateral leg using ultrasound and CT guidance. Five 25-gauge
needles were placed into the gastrocnemius muscle directly adja-
cent to the sites of vascular compression (Fig 2). After conﬁrma-
tion of needle placement, 200 units of Botox (Allergan, Irvine,
Calif) reconstituted in normal saline were injected under ultra-
sound guidance into each leg.
The patient returned to physical activity 2 days after the pro-
cedure. By 1 month after treatment the symptoms in the right leg
had resolved. The patient returned for follow-up imaging at
6 weeks. A repeat CT angiogram of the legs was performed at
identical levels of plantar ﬂexion force (63.5 kg) using the MVP
Flex. Imaging studies demonstrated complete resolution of the
functional popliteal artery entrapment bilaterally and nearly com-
plete resolution of the CAD of the right popliteal artery (Fig 3).
The cyst now measured 3  5  36 mm.
Fig 1. A, Resting axial short-tau inversion recovery magnetic resonance image of the right popliteal fossa demonstrates
cystic change in the popliteal artery (arrow). B, Axial stress computed tomography (CT) angiographic image of the
right leg at the level of the popliteal fossa demonstrates signiﬁcant arterial compression and cystic adventitial disease
(CAD) of the popliteal artery (arrow). C, Coronal stress CT angiographic image demonstrates the extent of cystic
change along the popliteal artery.
Fig 2. A, Patient positioned in the computed tomography (CT) scanner on the MVP FLEX (MVP Innovations,
Casper, Wyo) for stress imaging. The patient’s plantar ﬂexion force against resistance was monitored on the adjacent
screen. B, Needle placement in the popliteal fossa for injection.
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He will continue to be monitored with planned in-ofﬁce follow-
up and stress imaging at 6 months, 1 year, and 2 years. We also
plan on retreating the affected areas at w6 and 15 months after
the initial treatment to promote local muscle atrophy and muscle
retraining to prevent recurrence of the vascular compression.
DISCUSSION
Lower extremity vascular disease in young healthy men
is a rare medical condition. The case presented here de-
scribes a healthy young man with fPAES and CAD of the
popliteal artery. This case outlines a nonsurgical approach
to treating CAD likely caused by fPAES.
CAD is more common in men in the fourth or ﬁfth de-
cades of life. Cystic enlargement can produce mass effect
on the adjacent ﬂow lumen, thereby decreasing blood
ﬂow to the lower extremity. Proposed causes of CADinclude repeated microtrauma, ectopic aganglionosis, sys-
temic connective tissue disease, developmental abnormal-
ities, or synovial herniation.14 Pathology demonstrates a
collection of gelatinous material containing mucoproteins
and mucopolysaccharides located between the adventitia
and middle layer of the vessel wall.12,15
The diagnostic evaluation includes a thorough history
and physical examination. Most patients are asymptomatic
at rest, and the physical examination is normal. With stress
maneuvers, including passive dorsiﬂexion or active plantar
ﬂexion of the foot, symptoms may be reproduced,
including pain, paresthesia, and pallor, within the lower ex-
tremity. Imaging studies include vascular ultrasound, mag-
netic resonance angiography, or CT angiography. Stress
maneuvers should be performed during imaging examina-
tions to assist in identifying functional causes of vascular
injury, including PAES.
Fig 3. A, Axial stress computed tomography (CT) angiogram
6 weeks after treatment demonstrates a signiﬁcant reduction in the
cyst size (arrow) compared with the pretreatment image. B,
Coronal stress CT angiogram 6 weeks after treatment demon-
strates signiﬁcant reduction in the cyst size compared with the
pretreatment image (arrow).
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microtrauma. Arterial compression can result in early
arteriosclerosis and thrombus formation with associated
distal ischemia. In addition, the abnormal blood ﬂowmechanics can result in post-stenotic ectasia or aneurysm
formation.
Treatment of CAD primarily involves surgical resection
of the diseased segment with graft interposition, with vary-
ing degrees of success.7,8 Less invasive techniques,
including cyst aspiration and cyst resection, have also
been described with moderate success.16
The patient described above presented with severe
fPAES and CAD resulting in unilateral lower extremity
claudication. Treatment of fPAES in this patient resulted
in nearly complete cyst resolution and complete symptom
resolution by 6 weeks after treatment. The patient is
currently 5 months after treatment and remains asymptom-
atic and active in competitive sports. The technique used is
minimally invasive and targets the cause of the pathology,
which in this individual was likely functional popliteal artery
compression due to overdeveloped calf muscles in the
dominant leg. Examination and imaging using reproduc-
ible forces of plantar ﬂexion against resistance resulted in
a direct nonsubjective comparison of the muscles and
vasculature before and after treatment.
My experience using this diagnostic and treatment pro-
tocol in other patients with fPAES has the following
average results: (1) patients typically require three treat-
ments over a 2-year period, (2) localized atrophy of the
treated muscle was demonstrated on subsequent imaging,
and (3) no signiﬁcant side effects were noted, but occa-
sional transient muscle soreness and weakness have been
reported lasting 2 to 3 weeks.
CONCLUSIONS
CAD is a rare entity with limited treatment options.
The case presented suggests fPAES is one possible cause
of CAD. This patient was successfully treated using a mini-
mally invasive, imaging-guided intervention focally target-
ing the site of dynamic vascular compression. The patient
returned to sports without limitations or side effects from
the treatment. Imaging studies were performed with
controlled, reproducible, levels of muscle engagement
allowing direct comparison of before and after treatment
outcomes. The patient continues to remain asymptomatic
5 months after treatment.
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